Free Trial

Sarepta Therapeutics (SRPT) Earnings Date, Estimates & Call Transcripts

Sarepta Therapeutics logo
$126.29 +2.20 (+1.77%)
As of 01/3/2025 05:45 PM Eastern
Get Sarepta Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sarepta Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SRPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SRPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sarepta Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253$1.89$2.35$2.07
Q2 20253$1.99$2.64$2.24
Q3 20253$2.10$2.81$2.55
Q4 20253$2.18$2.84$2.57
FY 202512$8.16$10.64$9.43
Q1 20261$2.80$2.80$2.80
Q2 20261$3.66$3.66$3.66
Q3 20261$3.63$3.63$3.63

Sarepta Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/7/2024Q2 2024$0.01$0.07+$0.06$0.07$394.38M$362.90M
5/1/2024Q1 2024-$0.11$0.73+$0.84$0.39$375.52M$413.50M
2/28/2024Q4 2023-$0.03$0.47+$0.50$0.47$387.18M$396.80M
11/1/2023Q3 2023-$1.63$0.37+$2.00-$0.46$285.33M$331.80M
8/2/2023Q2 2023-$1.89-$0.27+$1.62-$0.27$255.99M$261.20M
5/2/2023Q1 2023-$1.46-$0.97+$0.49$2.98$241.47M$253.50M
2/28/2023Q4 2022-$1.28-$1.24+$0.04-$1.24$250.51M$258.43M

Sarepta Therapeutics Earnings - Frequently Asked Questions

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded annual revenue of $1.64 billion.

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded net income of -$535.98 million. SRPT has generated $1.25 earnings per share over the last four quarters.

Sarepta Therapeutics (NASDAQ:SRPT) has a trailing price-to-earnings ratio of 101.03 and a forward price-to-earnings ratio of 58.47.

Sarepta Therapeutics's earnings are expected to grow from $2.16 per share to $10.06 per share in the next year, which is a 365.74% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:SRPT) was last updated on 1/6/2025 by MarketBeat.com Staff
From Our Partners